A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

BACKGROUND: Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU 960) is a new long-acting injectable antipsychotic formulation for gluteal administration every 2 months, currently being investigated for the treatment of schizophrenia and bipolar I disorder (BP-I). The objectives of this trial were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Harlin, Matthew, Yildirim, Murat, Such, Pedro, Madera-McDonough, Jessica, Jan, Michael, Jin, Na, Watkin, Suzanne, Larsen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126081/
https://www.ncbi.nlm.nih.gov/pubmed/36961650
http://dx.doi.org/10.1007/s40263-023-00996-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126081/
https://www.ncbi.nlm.nih.gov/pubmed/36961650
http://dx.doi.org/10.1007/s40263-023-00996-8

Ejemplares similares